The knockdown of PKM2 inhibited the proliferation of breast cancer [70,71], thus indicating that Let-7-modulated PKM2 activity might be associated with the conversion of the original glucose metabolism pathway into cancer-favoring metabolic processes and sustained tumor malignancy. The gene discussed is PKM; the disease is neoplasm.